Achiko AG announced that it has successfully completed a production test with PT Indofarma Tbk as a precursor to mass production of its Generation 2 AptameX Covid-19 test kit. Generation 1 was successfully calibrated and delivered near perfect results earlier this year. Generation 2 is optimized for cost and production.

Earlier in 2022, the Company announced a sales and marketing contract with Nahdlatul Ulama, the world's Islamic organization with over 90 million registered members primarily in Indonesia. The plan was to deliver 5 million tests per month in Fourth Quarter 2022 rising to over 10 million per month in 2023. The contract is currently behind, however the Company expects to commence delivery as the Company enters the new year.